Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.

Sponsor
Prof A Gruca Teaching Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04446676
Collaborator
(none)
200
1
2
73.5
2.7

Study Details

Study Description

Brief Summary

Participants after first-stage of knee infection reimplantation will be assign to one of two groups: with stem vs. with sleeve. Investigators will check participants on clinical, laboratory and reinfection signs. The main hypothesis is that better mechanical stability of endoprosthesis with sleeves will support infection treatment.

Condition or Disease Intervention/Treatment Phase
  • Device: stabilization with stem
  • Device: stabilization with sleeve
N/A

Detailed Description

All participants will be treated because of periprosthetic joint infection of the knee, after primary arthroplasty. All participants will be treated with two-stage protocol. In first stage debridement and spacer implantation will be performed. After 6-week antibiotics, when will be absent clinical or laboratory signs of reinfection, second stage will be performed. All participants upon fulfillment all inclusion and exclusion criteria will sign informed consent. With computer software patients will be randomized to one of two groups: with stem vs. with sleeve. After operation all patients will get target antibiotics for 3 weeks. Pre-operation and after on periodic controls will checked the Knee Society Score, The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC), Visual Analogue Scale. After 2-year observation evaluation of reinfection rate will be performed in both groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two groups with endoprosthesis stabilisation with stem or sleeve.Two groups with endoprosthesis stabilisation with stem or sleeve.
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.
Actual Study Start Date :
Nov 17, 2020
Anticipated Primary Completion Date :
Jul 1, 2026
Anticipated Study Completion Date :
Jan 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Stem stabilization

Group of patients with stem endoprosthesis stabilization

Device: stabilization with stem
In both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.

Active Comparator: Sleeve stabilization

Group of patients with sleeve endoprosthesis stabilization

Device: stabilization with sleeve
In both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.

Outcome Measures

Primary Outcome Measures

  1. Reinfection [2 years]

    Rate of reinfection in both groups

Secondary Outcome Measures

  1. Loosening radiological signs [2 years]

    Radiological evaluation of implant loosening with Modern Knee Society Radiographic Evaluation System

Other Outcome Measures

  1. Knee Society Score [1 year]

    Clinical evaluation of patients after knee revision

  2. The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) [1 year]

    Clinical evaluation of patients after knee revision

  3. Visual Analogue Score [1 year]

    Clinical evaluation of patients after knee revision

  4. Alignment [6 weeks]

    Radiological alignment of knee after operation in degrees

  5. C-reactive protein [1 year]

    After operation and at period controls (mg/l)

  6. Erythrocyte sedimentation rate [1 year]

    After operation and at period controls (mm/h)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • second-stage of knee reimplantation

  • primary knee replacement in primary knee osteoarthritis

  • fulfillment of International Consensus Meeting 2018 infection criteria

Exclusion Criteria:
  • intraoperative bone defects Anderson Orthopedic Research Institute score >II

  • autoimmune disease

  • diabetes

  • peripheral vascular disease

  • congenital or acquired immunodeficiencies

  • lack of pathogens after first-stage

  • multi-bacterial infection

  • multidirectional instability

  • lack of patient consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gruca Teaching Hospital, Centre of Postgraduate Medical Centre Otwock Mazowieckie Poland 05-400

Sponsors and Collaborators

  • Prof A Gruca Teaching Hospital

Investigators

  • Principal Investigator: Paweł Bartosz, Prof. A. Gruca Teaching Hospital in Otwock

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bartosz Paweł, M.D., Ph.D., Prof A Gruca Teaching Hospital
ClinicalTrials.gov Identifier:
NCT04446676
Other Study ID Numbers:
  • Gruca Teaching Hospital
First Posted:
Jun 25, 2020
Last Update Posted:
Mar 15, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bartosz Paweł, M.D., Ph.D., Prof A Gruca Teaching Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2022